Contemporary Management Approaches for Newly Diagnosed Multiple Myeloma
Experts discussed the contemporary management of patients with newly diagnosed myeloma.
The Evolving Second-Line Treatment Landscape in HR+, HER2- Metastatic Breast Cancer
As part of its Case-Based Digest series, Oncology Nursing News spoke with experts about second-line treatment of HR-positive, HER2-negative metastatic breast cancer.
Bispecific Antibody Therapies in Multiple Myeloma
As part of the Community Case Forum series, key opinion leaders and participants discuss the use of bispecific antibodies the treatment of patients with multiple myeloma.
Second-Line Treatment for HR+, HER2- Metastatic Breast Cancer
In this Community Case Forum series, experts and participants discuss the evolving landscape of second-line treatment for patients with HR+, HER2- metastatic breast cancer.
CAR T-Cell Therapies for Multiple Myeloma
As part of its Community Case Forum series, key opinion leaders and participants discuss the use of CAR T-cell therapy for the treatment of patients with multiple myeloma.
Development of Immunotherapy for Advanced Endometrial Cancer
As part of its Community Case Forum series, key opinion leaders and participants discuss the development of immunotherapy for patients with advanced endometrial cancer.
Novel Drug Combo Is Promising for PD-L1-Resistant Solid Cancers
Mitazalimab Plus mFOLFIRINOX Improves Survival in Pancreatic Cancer
Novel ADC Shows Promise in Platinum-Resistant Ovarian Cancer
Chemo Should be Tailored to Decrease Neuropathy in Black Patients
